|
|
||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
In Practice 25: 615-618 (2003)
© 2003 British Veterinary Association
1 Anval
THERE will be significant implications for all practices if any changes to the retailing of veterinary medicines result in lower margins, reduced sales volumes, or both. Practices need to look very carefully at the business aspects of veterinary pharmacy in order to assess the impact of any changes and determine how best to react to them. As Peter Gripper explains in this article, a fundamental step in this process is to analyse the contribution of medicines sales to practice income and profits, as well as the true costs of supplying medicines.
| HOME | CURRENT ISSUE | TABLE OF CONTENTS | ARCHIVE | SEARCH | SUBSCRIPTIONS | EVENTS | FEEDBACK | HELP |